Skip to content

SWITCH-SAFE: Unraveling the (patho)physiological mechanisms and potential clinical benefits of an early switch from controlled to assisted ventilation

SWITCH-SAFE: Unraveling the (patho)physiological mechanisms and potential clinical benefits of an early switch from controlled to assisted ventilation - SWITCH-SAFE

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56663
Enrollment
20
Registered
2023-12-06
Start date
2024-09-16
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute respiratory failure

Interventions

The treatment intervention is a pre-specified switch from controlled to assisted ventilation when PaO2/FiO2 ratio reaches >= 200 mmHg.

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • At least 18 years old • Written informed consent • Mechanical ventilation via an endotracheal tube • Acute hypoxemic respiratory failure with PaO2/FiO2 ratio

Exclusion criteria

Exclusion criteria: • Expected mechanical ventilation duration of 0.5 gamma) and/or fluids, and/or heart rate

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the change in regional lung stress when switching from controlled to assisted ventilation and until a successful or failed switch. This will be derived from electrical impedance tomography (EIT) recordings by computing the ventilation distribution (parameter reflecting lung and ventilation inhomogeneity).

Secondary

MeasureTime frame
Secondary endpoints include other EIT-derived parameters, lung tissue characteristics on PCCT scan, respiratory mechanics, breathing effort, ventilator-free days, patient-ventilator interaction, gas exchange and hemodynamics, and inflammatory biomarkers.

Countries

Netherlands

Contacts

Public ContactA.H. Jonkman

Erasmus MC, Universitair Medisch Centrum Rotterdam

researchICV@erasmusmc.nl010-7035142

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026